The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     
9 pts

Opinion on  Alexion Pharmaceuticals Inc. (ALXN)     Sector: Healthcare  >  Industry: Biotechnology & Drugs
ALXN $6 to $12 Target Price Range - Overvalued in Industry

Oct 23, 2008 10:10 PM GMT
Return Risk
+7.53% LOW
Associate

Favorable/Unfavorable Valuation  

ALXN's projected P/E is 49.50
Industry (Drug Manufacturers - Other) average projected P/E 16.16
Implies a projected stock price of $12.93

ALXN's PEG is 11.27
ALXN's projected earnings growth rate is 4.39%
Industry (Drug Manufacturers - Other) average PEG is 1.86
Implies a projected stock price of $6.54

More analysis source, calculations, and other info:

http://www.freestockvalueranker.com/?method=peg_pe&symbol...

Analysis current as of October 23, 2008 5:00 PM


ALXN:  This call was made on 10/23/08 @ $37.2
Rating:   Negative   $37.2 (10/23/08)
Gain/Loss:   -21.48% in 378 days
Target:   $12.00 (-67.74%) in Three months


Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 noshoes 21.10 +35.25% 368
2 Gerald Greene 18.14 +70.90% 206
3 stockmarketfunding.com 17.66 +25.78% 53
4 akiralegrand 13.47 +14.32% 60
5 anup2104 12.13 +69.23% 34


POPULAR STOCKS
Symbol Company Name Sentiment
SBUX Starbucks Corp
FNM Fannie Mae
PFE Pfizer Inc
GM General Motors Corp
MSFT Microsoft Corp
V Visa Inc

TODAY'S HEADLINES

TODAY'S TOP PICKS

 
Alexion Pharmaceuticals Inc. (ALXN)
   SocialPicks Sentiment:   

   This Quarter's Sentiment:
All:
58.0%
Top:
100.0%




Latest Picks by energycurve
Symbol SP Sentiment Rating Return Since
EMC Neutral/Hold +57.84% 11/06/08
CCI N/A Negative -84.62% 10/28/08
WHR Positive +53.82% 10/28/08
FDRY Negative +7.45% 10/23/08
TRC Negative +0.46% 10/23/08

View All >
   




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch